Household Products

Coco Healthcare

Coco Healthcare released FY2026 Q1 earnings on April 26 After-Market (BJT), actual revenue CNY 291.3 M, actual EPS CNY 0.0071

Coco Healthcare released FY2025 Q4 earnings on April 26 Pre-Market (BJT), actual revenue CNY 320.74 M, actual EPS CNY 0.035

Coco Healthcare released FY2025 annual earnings on April 26 Pre-Market (BJT), actual revenue CNY 1.15 B (forecast CNY 1.144 B), actual EPS CNY 0.14 (forecast CNY 0.13)

Coco Healthcare FY2026 Q1 Earnings Release on April 25 After-Market (BJT)

Coco Healthcare FY2025 Annual Earnings Release on April 25, 2026 Pre-Market (BJT), Forecast Revenue CNY 1.144 B, EPS CNY 0.13

Coco Healthcare released FY2025 9-month earnings on October 27 After-Market BJT, actual revenue CNY 829.49 M, actual EPS CNY 0.105

Coco Healthcare released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 280.53 M, actual EPS CNY -0.0011

Coco Healthcare to Release FY2025 Q3 Earnings on October 28 After-Market (BJT)

Coco Healthcare released FY2025 Semi-Annual earnings on August 24 After-Market (BJT), actual revenue CNY 548.96 M, actual EPS CNY 0.1061

Coco Healthcare released FY2025 Q2 earnings on August 24 After-Market (BJT), actual revenue CNY 268.78 M, actual EPS CNY 0.0363

Coco Healthcare to Release FY2025 Semi-Annual Earnings on August 25, 2025 (BJT)

Reliable Holdings Explains Reasons for Decreasing Revenue 2020-2024 and 2025 Strategy

Tianfeng Securities Issues Buy Rating for Kexiao Shares

Keli Shares Listed on Zhejiang Province's Advanced Smart Factories List

Reliable Shares Up 5.53%, Wind Securities Gives Buy Rating

Reco Holdings Shareholder Calls for Extraordinary General Meeting to Review Related Party Transactions

TS Securities Gives Buy Rating to Reliable Shares

Reliable Co. and Jiangsu Cable Release Business Growth Plans

Reliable Stock Price Rises with Buy Rating from Tianfeng Securities

Reliable Holdings Revenue Down, Net Profit Up in Q1 2025

301009

Coco Healthcare has removed independent director Jing Naiquan from his position, attracting market attention. The company announced that he has lost his independence, failed to fulfill his duties, and lacks professional ethics. Secretary of the Board Wang Xiangting stated that the key to the removal decision was Jing Naiquan's disregard for the interests of the company and minority shareholders in the salary dispute involving director Bao Jiaxin, violating the company's compensation plan

Wallstreetcn

Coco Healthcare "dismisses" independent director, causing controversy; company secretary responds

Coco Healthcare announced that the company recently signed a "Share Acquisition Intent Agreement" with Hanhe Paper Industry and its shareholder Wu Jie, intending to acquire no less than 60% of the target company's equity in cash and achieve control over Hanhe Paper Industry. The overall valuation of 100% equity of the target company is tentatively set at no more than RMB 650 million, and the valuation of 100% equity of the target company and the pricing of this transaction will ultimately be subject to the audit assessment report and the formally signed acquisition agreement

Zhitong

Coco Healthcare: Plans to sign a letter of intent for equity acquisition

600315

The beauty and personal care sector adjusted, with Zhongshun Jierou hitting the daily limit down, and Shanghai Jahwa, Beijia Clean, Coco Healthcare, Lihe Kechuang, Jieya Co., Ltd., and Jinbo Biological all following suit

Shanghai Jahwa

The beauty and personal care sector adjusts, Zhongshun Jierou hits the limit down

Coco Healthcare announced that its revenue for the third quarter was 281 million yuan, an increase of 4.59% year-on-year; the net profit loss was 294,200 yuan, a decrease of 74.28%. The revenue for the first three quarters was 829 million yuan, an increase of 5.12% year-on-year; the net profit was 27.9844 million yuan, an increase of 26.79%

Coco Healthcare: Net profit loss of 294,200 yuan in the third quarter, a decrease of 74.28%

Coco Healthcare disclosed its 2025 semi-annual report on the evening of August 24, achieving an operating income of 549 million yuan in the first half of the year, a year-on-year increase of 5.39%; the net profit attributable to the parent company was 28.2786 million yuan, a year-on-year increase of 21.81%; basic earnings per share were 0.1061 yuan

Coco Healthcare: Net profit in the first half of the year was 28.2786 million yuan, a year-on-year increase of 21.81%

001222

301335

300673

The concept of pet economy is rising, as of the time of writing, Coco Healthcare has risen by over 8%, with YUANFEI PET, Tianyuan Pet Products, Petpal Tech., and others following suit

YUANFEI PET

Tianyuan Pet Products

Petpal Tech.

Pet economy concept rises, Coco Healthcare up over 8%

Coco Healthcare announced that its shareholder Hangzhou Weiaino plans to reduce its holdings from August 15, 2025, to November 14, 2025. Specifically, Hangzhou Weiaino will reduce its holdings by no more than 4.2312 million shares, accounting for 1.56% of the total share capital; Hangzhou Weiaino No. 2 plans to reduce its holdings by no more than 1.353 million shares, accounting for 0.50% of the total share capital; Hangzhou Weiaino No. 3 plans to reduce its holdings by no more than 1.5588 million shares, accounting for 0.57% of the total share capital

Coco Healthcare: Specific shareholder Wei Ainu plans to reduce holdings by 1.56%

603193

300886

603630

300955

The beauty and personal care sector is rising, with Runben Biotechnology hitting the daily limit, JAHEN rising over 10%, and Shanghai Jahwa, Hyea Aromas, Lafang, BAWI, Coco Healthcare, and others following suit

Runben Biotechnology

Hyea Aromas

Lafang

JAHEN

The beauty and personal care sector rises, Runben Biotechnology hits the limit up

300703

001206

003030

The pet economy concept has rebounded sharply, with Daqian Ecology hitting the limit up, and Lionhead Co., Ltd., Century Hengtong, Cre8 Direct, YIYI, Zuming Bean, and Coco Healthcare also rising

Cre8 Direct

YIYI

Zuming Bean

002348

300043

New consumption concept stocks fell sharply, with Cre8 Direct and Coco Healthcare down over 8%, and Rastar, Dechuang Cultural and Creative, and GOLDLOK HOLDINGS down over 6%

GOLDLOK HOLDINGS

Rastar

Coco Healthcare(301009.SZ)